
浏览全部资源
扫码关注微信
广西中医药大学基础医学院生理学教研室,南宁 530200
副教授,硕士生导师,博士。研究方向:天然产物防治代谢性疾病的基础研究。E-mail:965643897@qq.com
教授,硕士生导师,博士。研究方向:中草药天然产物防治代谢性疾病的基础研究。E-mail:116190888@qq.com
收稿:2026-01-08,
修回:2026-03-18,
录用:2026-04-20,
纸质出版:2026-05-15
移动端阅览
陈永欣,李宇轩,顾凯磊,等.杨桃根活性成分DMDD对糖尿病小鼠心肌损伤的保护作用及其与NCOA4/FTH1/ATG8轴的相关性研究 [J].中国药房,2026,37(09):1141-1147.
CHEN Yongxin,LI Yuxuan,GU Kailei,et al.Protective effect of the active component DMDD from Averrhoa carambola root on myocardial injury in diabetic mice and its correlation with the NCOA4/FTH1/ATG8 axis[J].ZHONGGUO YAOFANG,2026,37(09):1141-1147.
陈永欣,李宇轩,顾凯磊,等.杨桃根活性成分DMDD对糖尿病小鼠心肌损伤的保护作用及其与NCOA4/FTH1/ATG8轴的相关性研究 [J].中国药房,2026,37(09):1141-1147. DOI: 10.6039/j.issn.1001-0408.2026.09.06.
CHEN Yongxin,LI Yuxuan,GU Kailei,et al.Protective effect of the active component DMDD from Averrhoa carambola root on myocardial injury in diabetic mice and its correlation with the NCOA4/FTH1/ATG8 axis[J].ZHONGGUO YAOFANG,2026,37(09):1141-1147. DOI: 10.6039/j.issn.1001-0408.2026.09.06.
目的
2
基于核受体共激活因子4/铁蛋白重链1/自噬相关蛋白8(NCOA4/FTH1/ATG8)轴探讨杨桃根活性成分2-十二烷基-6-甲氧基-2,5-二烯-1,4-环己二酮(DMDD)对糖尿病小鼠心肌损伤的保护作用。
方法
2
将造模成功的糖尿病小鼠随机分为模型组和DMDD低、中、高剂量组(12.5、25、50 mg/kg),另设不造模的对照组,每组6只。各组小鼠分别灌胃相应药液或生理盐水,每天1次,连续21 d。给药结束后,检测小鼠空腹血糖(FBG)、血清中乳酸脱氢酶(LDH)及肌酸激酶同工酶MB(CK-MB)水平;观察心肌病理变化、纤维化程度及心肌细胞超微结构;检测心肌细胞死亡指数、NCOA4蛋白阳性指数;检测心肌组织中NCOA4、FTH1、ATG8、溶质载体家族7成员11(SLC7A11)及谷胱甘肽过氧化物酶4(GPX4)蛋白表达水平。
结果
2
与模型组比较,DMDD各剂量组小鼠心肌损伤明显缓解,心肌细胞超微结构亦有不同程度改善;小鼠FBG,血清中LDH、CK-MB水平,心肌细胞死亡指数、NCOA4蛋白阳性指数,心肌组织中NCOA4、FTH1、ATG8蛋白表达水平均显著降低(
P
<0.001),而SLC7A11、GPX4蛋白表达水平均显著升高(
P
<0.001)。
结论
2
DMDD可降低糖尿病小鼠血糖水平,减轻心肌组织病理损伤,并抑制细胞死亡,其机制与抑制NCOA4/FTH1/ATG8轴过度激活、减少铁自噬有关。
OBJECTIVE
2
To investigate the protective effect of 2-dodecyl-6-methoxy-2,5-diene-1,4-cyclohexanedione (DMDD), an active component from
Averrhoa carambola
root, on myocardial injury in diabetic mice based on the nuclear receptor coactivator 4/ferritin heavy chain 1/autophagy-related protein 8 (NCOA4/FTH1/ATG8) axis.
METHODS
2
The successfully modeled diabetic mice were randomly divided into model group and DMDD low-, medium-, and high-dose (12.5, 25, 50 mg/kg) groups, while an additional non-modeled control group was established, with 6 mice in each group. Each group received the corresponding drug solution or an equal volume of normal saline intragastically once daily for 21 consecutive days. After the administration, the levels of fasting blood glucose (FBG), serum lactate dehydrogenase (LDH), and creatine kinase isoenzyme MB (CK-MB) were measured. Myocardial pathological changes, degree of fibrosis, and myocardial cell ultrastructure were observed. Myocardial cell death index and NCOA4 protein positive index were detected. The protein expression levels of NCOA4, FTH1, ATG8, solute carrier family 7 member 11 (SLC7A11), and glutathione peroxidase 4 (GPX4) in cardiac tissue were measured.
RESULTS
2
Compared with model group, each DMDD group showed significant alleviation of cardiac pathological injury and varying degrees of improvement in the myocardial cell ultrastructure. The FBG and serum LDH and CK-MB levels, the myocardial cell death index and NCOA4 protein positive index,the protein expression levels of NCOA4, FTH1, and ATG8 in cardiac tissue were significantly decreased (
P
<0.001), while the protein expression levels of SLC7A11 and GPX4 were significantly increased (
P
<0.001).
CONCLUSIONS
2
DMDD can reduce blood glucose levels, alleviate myocardial histopathological injury, and inhibit cell death in diabetic mice. The mechanism is associated with inhibiting excessive activation of the NCOA4/FTH1/ATG8 axis and reducing ferritinophagy.
ORTEGA H I , UDLER M S , GLOYN A L , et al . Diabetes mellitus polygenic risk scores:heterogeneity and clinical translation [J ] . Nat Rev Endocrinol , 2025 , 21 ( 9 ): 530 - 545 .
KAMAKSHI SHRIYA A S , PAWAR V B , PAUL A A . Diabetic heart disease:an intricate interplay of a widespread metabolic disorder with the cardiovascular system [J ] . Curr Diabetes Rev , 2024 , 21 ( 6 ): e110724231859 .
BELLEMARE M , BOURCIER L , IGLESIES-GRAU J , et al . Mechanisms of diabetic cardiomyopathy:focus on inflammation [J ] . Diabetes Obes Metab , 2025 , 27 ( 5 ): 2326 - 2338 .
PREDA A , MONTECUCCO F , CARBONE F , et al . SGLT2 inhibitors:from glucose-lowering to cardiovascular benefits [J ] . Cardiovasc Res , 2024 , 120 ( 5 ): 443 - 460 .
SHI J M , WANG Y X , LIANG T , et al . DMDD,isolated from Averrhoa carambola L.,ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-autophagy crosstalk [J ] . Chin Med , 2024 , 19 ( 1 ): 125 .
马静 , 吴娅妮 , 黄德伦 , 等 . 杨桃根DMDD调控ROS介导的自噬通路减轻糖尿病大鼠心肌损伤 [J ] . 中国药理学通报 , 2021 , 37 ( 6 ): 823 - 827 .
ZHANG X Y , DONG X F , JIE H P , et al . Downregulation of the (pro)renin receptor alleviates ferroptosis-associated cardiac pathological changes via the NCOA4-mediated ferritinophagy pathway in diabetic cardiomyopathy [J ] . Int Immunopharmacol , 2024 , 138 : 112605 .
WANG Y , ZHANG Y , GAO M , et al . Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy [J ] . Cell Death Dis , 2024 , 15 ( 11 ): 865 .
FUJIOKA Y , TSUJI T , KOTANI T , et al . Phase separation promotes ATG8 lipidation and vesicle condensation for autophagy progression [J ] . Nat Struct Mol Biol , 2025 , 32 ( 11 ): 2285 - 2295 .
谢静晓 , 王誉湘 , 张晓萍 , 等 . 杨桃根DMDD调控JNK/P38MAPK通路抑制2型糖尿病合并非酒精性脂肪肝小鼠肝脏内质网应激 [J ] . 广西医科大学学报 , 2023 , 40 ( 5 ): 786 - 791 .
LORENZO-ALMORÓS A , CEPEDA-RODRIGO J M , LORENZO Ó . Diabetic cardiomyopathy [J ] . Rev Clin Esp , 2022 , 222 ( 2 ): 100 - 111 .
XU B T , WAN S R , WU Q , et al . BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2 [J ] . Cardiovasc Diabetol , 2025 , 24 ( 1 ): 101 .
NIU W P , LIU X , DENG B , et al . Piezo1 deletion mitigates diabetic cardiomyopathy by maintaining mito- chondrial dynamics via ERK/Drp1 pathway [J ] . Cardiovasc Diabetol , 2025 , 24 ( 1 ): 127 .
LI W Y , LI W , WANG Y , et al . Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated ferritino- phagy during diabetes myocardial ischemia/reperfusion injury [J ] . Cell Death Discov , 2021 , 7 : 267 .
ZHANG S Z , TIAN W C , DUAN X X , et al . Melatonin attenuates diabetic cardiomyopathy by increasing autophagy of cardiomyocytes via regulation of VEGF-B/GRP78/PERK signaling pathway [J ] . Cardiovasc Diabetol , 2024 , 23 ( 1 ): 19 .
NAGAKANNAN P , ISLAM M I , SULTANA S , et al . TXNIP promotes ferroptosis through NCOA4 mediated ferritinophagy [J ] . Biochim Biophys Acta BBA Mol Cell Res , 2025 , 1872 ( 8 ): 120054 .
WU H , LIU Q , SHAN X Y , et al . ATM orchestrates ferritinophagy and ferroptosis by phosphorylating NCOA4 [J ] . Autophagy , 2023 , 19 ( 7 ): 2062 - 2077 .
LI H H , WANG X T , ZHANG Y , et al . SLC39A13 regulates heart function via mitochondrial iron homeostasis maintenance [J ] . Circ Res , 2025 , 137 ( 6 ): e144 - e156 .
LUO C Y , LIANG H S , JI M T , et al . Autophagy induced by mechanical stress sensitizes cells to ferroptosis by NCOA4-FTH1 axis [J ] . Autophagy , 2025 , 21 ( 6 ): 1263 - 1282 .
SONG J Z , LI H , YANG H Y , et al . Recruitment of Atg1 to the phagophore by ATG8 orchestrates autophagy machineries [J ] . Nat Struct Mol Biol , 2025 , 32 ( 9 ): 1606 - 1621 .
HOELZGEN F , NGUYEN T T P , KLUKIN E , et al . Structural basis for the intracellular regulation of ferritin degradation [J ] . Nat Commun , 2024 , 15 : 3802 .
ZHANG M , ZHENG H , JIN H , et al . Regulating SLC7A11/GSH/GPX4 axis by glucose dyshomeostasis to simultaneously promote disulfidptosis,cuproptosis and ferroptosis [J ] . Bioact Mater , 2025 , 54 : 744 - 758 .
0
浏览量
6
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621